GlassScriptPhysician profile
Gin-Ming Hsu
NPI 1265415988
$7,629.33
in general payments reported to CMS, 2019-2025
41 companies · $1,760 in 2025
The $1,760 reported for 2025 was more than what 92% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $912 · 2021: $976 · 2022: $1,356 · 2023: $1,066 · 2024: $859 · 2025: $1,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,597 · Travel and Lodging: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,597.16 |
| Travel and Lodging | $1,087.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $1,287.15 | 2022-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $1,062.51 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $860.31 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $446.56 | 2019-2025 | Relistor |
| Allergan, INC. | $422.51 | 2019-2022 | |
| Boston Scientific Corporation | $403.67 | 2019-2024 | G4 Rf Generator, Infinion 16, Wavewriter Alpha Prime 16 |
| Ipsen Biopharmaceuticals, INC | $362.08 | 2019-2025 | Dysport |
| Saluda Medical Americas, INC. | $277.17 | 2023-2025 | Evoke, Evoke Scs |
| Amgen INC. | $264.78 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $227.67 | 2021-2022 | |
| Bioventus LLC | $194.89 | 2019-2025 | Gelsyn-3 |
| Scilex Pharmaceuticals INC. | $182.01 | 2021-2023 | Ztlido |
| Mml US, INC. | $163.79 | 2022 | |
| Abbott Laboratories | $139.90 | 2023 | Eterna |
| Nevro Corp. | $134.03 | 2019-2023 | Senza |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gin-Ming Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.